Clinical Trials Directory

Trials / Completed

CompletedNCT04890470

Effects of Oxytocin and Vasopressin on Moral Decision Making

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

To determine whether the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making

Detailed description

In a double-blind, between- subject placebo (PLC) controlled design, subjects will first complete a series of questionnaires in terms of mood, clinical symptoms, and traits. After that their moral judgment and emotion towards both verbal descriptions of moral dilemma scenarios and pictures of specific interpersonal ones will be assessed and the effect of intranasal OXT and AVP between both male and female healthy subjects will be investigated.

Conditions

Interventions

TypeNameDescription
DRUGOxytocinintranasal administration of oxytocin (24 IU)
DRUGVasopressinintranasal administration of vasopressin (20 IU)
DRUGPlacebointranasal administration of placebo

Timeline

Start date
2021-03-02
Primary completion
2022-12-12
Completion
2022-12-12
First posted
2021-05-18
Last updated
2023-09-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04890470. Inclusion in this directory is not an endorsement.